Real-world (RW) study of metastatic colorectal cancer (mCRC) patients (pts) with long-term response (LTR) to regorafenib (REG) in the USA: An updated analysis

被引：0
|
作者：
Kim, R. D. [1 ]
Pan, X. [2 ]
Zhang, Y. [2 ]
Lunacsek, O. [2 ]
Pisa, F. [3 ]
Ostojic, H. [4 ]
Peeters, M. [5 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Gastrointestinal Oncol, Tampa, FL USA
[2] Bayer Healthcare Pharmaceut Inc, Real World Evidence Oncol, Whippany, NJ 07981 USA
[3] Bayer AG, Real World Evidence Oncol, Berlin, Germany
[4] Bayer Consumer Care AG, Real World Evidence Oncol, Basel, Switzerland
[5] Univ Hosp Antwerp, Ctr Oncol Res, Edegem, Belgium
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.094
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
83P
引用
收藏
页码：S41 / S41
页数：1
相关论文
共 50 条
  • [1] Real-world (RW) study in patients (pts) with metastatic colorectal cancer (mCRC) with long-term responses to regorafenib in the USA.
    Kim, Richard D.
    Pan, Xiaoyun
    Ostojic, Helene
    Zhang, Yiqiao
    Lunacsek, Orsolya
    Pisa, Federica
    Peeters, Marc
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 48 - 48
  • [2] Real world (RW) use and outcomes of regorafenib (REG) flexible dosing in patients (pts) with metastatic colorectal cancer (mCRC) in Europe
    Peeters, Marc
    Chibaudel, Benoist
    Barzi, Afsaneh
    Ostojic, Helene
    Pan, Xiaoyun
    Yasuda, Marie
    Chen, Chi-Chang
    Multani, Jasjit
    Casey, Vicky
    Vassilev, Zdravko
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 47 - 47
  • [3] Long-term response to regorafenib (REG) in patients with metastatic colorectal cancer (mCRC): A systematic literature review (SLR)
    Peeters, M.
    Pan, X.
    Koufopoulou, M.
    Arregui, M.
    Wissinger, E.
    Ostojic, H.
    Pisa, F.
    Kim, R. D.
    ANNALS OF ONCOLOGY, 2024, 35 : S30 - S31
  • [4] Real-world adherence in patients with metastatic colorectal cancer (mCRC) treated with trifluridine/tipiracil (FTD/TPI) or regorafenib (REG).
    Patel, Anuj K.
    Barghout, Victoria
    Yenikomshian, Mihran Ara
    Germain, Guillaume
    Jacques, Philippe
    Laliberte, Francois
    Duh, Mei Sheng
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (30)
  • [5] Real-world dosing of regorafenib (REG) in metastatic colorectal cancer (mCRC): Final results from the prospective, observational CORRELATE study
    O'Connor, J. M.
    Ducreux, M.
    Petersen, L. N.
    Oehler, L.
    Bergamo, F.
    Metges, J-P.
    de Groot, J. W.
    Wang, J-Y.
    Garcia Paredes, B.
    Dochy, E.
    Fiala-Buskies, S.
    Cervantes, A.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [6] Pharmacokinetics of regorafenib (REG) in the phase 3 CONCUR and CORRECT trials in patients (pts) with metastatic colorectal cancer (mCRC)
    Cleton, A.
    Sturm, I.
    Trnkova, Z. Jirakova
    Grevel, J.
    Fiala-Buskies, S.
    Lettieri, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 10 - 10
  • [7] Age-related real-world outcomes for patients (pts) with metastatic colorectal cancer (mCRC).
    Curtis, Melissa
    Nussbaum, Nathan Coleman
    Hamrick, Harvey J.
    Bennette, Caroline Savage
    Meropol, Neal J.
    Miksad, Rebecca A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] Regorafenib plus tislelizumab for patients with metastatic colorectal cancer: A real-world study
    Gao, Xiang
    Chen, Xiaoping
    Zhao, Yutian
    Mao, Yong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] Real-world dosing of regorafenib in metastatic colorectal cancer (mCRC): Interim analysis from the prospective, observational CORRELATE study
    Manuel, O'Connor Juan
    Leopold, Oehler
    Werner, Scheithauer
    Jean-Philippe, Metges
    Louis-Marie, Dourthe
    Willem, de Groot Jan
    Josef, Thaler
    Kun-Huei, Yeh
    Jen-Kou, Lin
    Alfredo, Falcone
    Punt, Cornelis J. A.
    Jan, Kalinovsky
    Sabine, Fiala-Buskies
    Andres, Cervantes
    Petersen, Lone N.
    Michel, Ducreux
    ANNALS OF ONCOLOGY, 2017, 28
  • [10] Treatment modalities of regorafenib and survival in metastatic colorectal (mCRC) patients: A real-world multicenter retrospective study
    Qu, Wang
    Liu, Zimin
    Zhu, Liangjun
    Chen, Xiaobing
    Liu, Bo
    Zhao, Yun-Bo
    Yan, Hao
    Qu, Xiujuan
    Li, Shengmian
    Zang, Ai-Min
    Jiang, Zhichao
    Sun, Yongkun
    Zhou, Ai-Ping
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345